Epoetin alpha in the treatment of anemia in patients with malignant solid tumors during antitumor drug therapy

Epoetin alpha in the treatment of anemia in patients with malignant solid tumors during antitumor drug therapy

Introduction. Erythropoietin (EPO) application is a pathogenetic method for anemia correction in cancer patients.The purpose of study. Clinical evaluation of the efficacy and safety of Eralfon® (epoetin alpha) in treatment for anemia in patients with malignant solid tumors during medical anticancer...

Full description

Bibliographic Details
Main Authors: L. Yu. Vladimirova, N. A. Abramova, A. A. Lyanova, A. E. Storozhakova, I. L. Popova, M. A. Teplyakova, N. M. Tikhanovskaya, L. A. Ryadinskaya, E. A. Kalabanova, S. N. Kabanov, I. A. Udalenkova
Format: Article
Language:Russian
Published: Remedium Group LLC 2022-06-01
Series:Медицинский совет
Subjects:
anemia
erythropoietins
malignant solid tumors
antineoplastic therapy
epoetin alpha
Online Access:https://www.med-sovet.pro/jour/article/view/6924

Internet

https://www.med-sovet.pro/jour/article/view/6924

Similar Items